Good health care should not be a luxury
We're on a mission to revolutionize women's health care.
We aspire to significantly enhance the quality of life and care of women by empowering patients and health care professionals with intelligent drug delivery and diagnostics. We are developing a unique platform in the field of smart therapies with a market launch planned in 2024 that has the potential to transform the way women are treated, monitored, and diagnosed.
Our supporters
How unique it is to be able to personally adjust the administration of medicine in the MedRing as a woman!!
Marlies Bongers, Prof. MD PhD
It is refreshing to see novel initiatives such as the MedRing, which offers a potential paradigm shift for drug delivery and diagnostics. I expect its clinical applications will transform the treatment of women’s health.
Karolina Afors, MBBS BSc MRCOG
I have followed the development of LiGalli and the revolutionary vaginal ring, and I am extremely impressed with this innovation. This ring encapsulates the essence of modern technology, finding a solution that seamlessly fits into today’s society and empowers women.
Louise Hansen
The MedRing’s modern, personalized approach to women’s health has the potential to dramatically shift the health of people around the world. By letting people manage their treatment in the palm of their hand, the MedRing enables people to have more power over their health and health outcomes.
Amanda Srsic, MPH
Meet the leadership team
Godert Vinkesteijn MSc, RC
CFO
Judith Bolle MSc
DIRECTOR BUSINESS DEVELOPMENT
Victor Nickolson PhD
DIRECTOR PRE-CLINICAL & PHARMA
Maarten Wiegerinck MD, PhD
DIRECTOR CLINICAL & SENSORING
Martin Walraven MSc, Pharmacist
DIRECTOR OPERATIONS
Thijs van Oorschot MSc
DIRECTOR TECHNOLOGY & IT
Barry van Amsterdam MSc
DIRECTOR BUSINESS VALUATION
Willem de Laat, MD, PhD, MBA
FOUNDER & BOARD MEMBER
Willem is the visionary father and founder of LiGalli and now, after his previous position as CEO, a member of the supervisory board.
Marga Mathijssen, MSc
CEO
Marga is an experienced business leader with a solid track record to grow businesses across the world. Developing winning strategies and establishing high performing teams are her key competencies. She has a passion for improving healthcare.
Godert Vinkesteijn, MSc, RC
CFO & BOARD MEMBER
Godert is a keen businessman and professional investor. He was involved in the setup of LiGalli from the early beginnings. His expertise lies in telecom and data management but also in corporate finance.
Thijs van Oorschot, MSc
DIRECTOR TECHNOLOGY & IT
Thijs is a MedTech entrepreneur with a background in industrial design engineering, bringing extensive experience in (medical) product development, production, and quality management.
Tanja Breum, MSc
BUSINESS DEVELOPMENT
Tanja has extensive international business development experience, ranging from licensing to co-development deals. Her expertise is in finding and creating ideal strategical partnerships.
Martin Walraven, MSc, Pharmacist
DIRECTOR OPERATIONS
Martin is an experienced project manager. He spent his whole life working for various top 20-ranking international pharmaceutical companies, bringing innovative products from research to commercialization.
Oda Heerema-Snoep, MSc
MANAGER PRODUCT USABILITY
& USER EXPERIENCE
Oda has broad experience in medical proposition development. She connects the dots between the end user, the clinical experts and the development team.
Andrea Brand, MSc
DIRECTOR PURCHASE & OPERATIONAL PARTNER MANAGEMENT
Andrea has profound international experience in procurement and partner management. She drives strategic business change and efficiency through cooperations.
Freek Vercauteren, BSc
SPECIALIST PROCUREMENT & OPERATIONAL PARTNER MANAGEMENT
Freek has gained experience in supply chain, procurement, finance and sales for various industries. He is good a developing a secure supply chain with partners around the globe.
Maarten Wiegerinck, MD, PhD
DIRECTOR CLINICAL & SENSORING
Maarten is the creative mind of the company, having developed innovative devices and believing in the diagnostic potential of the mucosal wall ever since he did his thesis work on the topic.
Marjolein Jongboer
QUALITY MANAGER
Marjolein is a quality & assurance specialist with over 25 years experience in the medical devices industry. She is a dedicated group motivator and driven people manager with an emphasis on team-play.
Marie-Pauline Luger, MSc
DIRECTOR BRAND MANAGEMENT
& COMMUNICATION
Marie-Pauline is specialized in healthcare marketing and the positioning of medical products and services.
Barry van Amsterdam, MSc
DIRECTOR BUSINESS VALUATION
Barry has developed an innovative new valuation model as a certified valuation manager and has implemented it in the business case of LiGalli’s lead compound.
Victor Nickolson, PhD
DIRECTOR PRE-CLINICAL & PHARMA
Victor has researched many different molecules in his career and developed many new medications. He has a broad interest in the pharmaceutical market as well as in the technical aspects of medical devices and diagnostic principles.
Eveline Moret
CLINICAL TRIAL ASSISTANT
Eveline is an ultrasonographer, specialized in fertility, and co-worker in clinical trials and supporting patients.
Why we care
women are underrepresented
- Women’s health has been underrepresented in medical investment, research, and innovation.
- Medical solutions for women have not yet been fully explored because a male-first approach has been adopted.
We prioritize the wellbeing of women and offer personalized treatment.
existing solutions are challenging
- Millions of women experience problems, side effects, and intolerability related to the current treatments.
- Women are 50-75% more likely to have adverse reaction to medications than men.
The vaginal wall facilitates rapid uptake of drugs and avoids the major side effects associated with swallowing a pill.
technology is outdated
- The lack of innovation in women’s health has led to current solutions that do not adequately support women.
- This stagnation is leading to poorer quality of life and lower health outcomes.
The MedRing combines intelligent drug delivery and diagnostics to advance women’s health.
Life is complicated.
Your health care
shouldn't be.
Meet the supervisory board
Cees van den Heijkant,MBA
CHAIRMAN OF THE BOARD
Cees is a mature and senior businessman and entrepreneur as well as professional investor. Cees successfully invests in IT/tech companies, sometimes jointly with PE funds, as well as in start-ups with disruptive character.
Willem de Laat,MD, PhD, MBA
BOARD MEMBER
Willem is the visionary father and founder of LiGalli and now, after his previous position as CEO, a member of the supervisory board.
Godert Vinkesteijn, MSc, RC
BOARD MEMBER& CFO
Godert is a keen businessman and professional investor. He was involved in the setup of LiGalli from the early beginnings. His expertise lies in telecom and data management but also in corporate finance.
Carl Thys, MSc, Pharmacist
BOARD MEMBER
Carl is Managing Partner at Eagle Rock LS. Carl developed his deep understanding of the pharmaceutical industry through various marketing and sales positions in leading corporations. His current consultancy business has only added more weight to his expertise.
We partner with the best and
most creative minds.
Our successful and diverse partnerships have leveraged ambition, innovation, and results.
Our endorsers
Prof. Douwe D. Breimer
LEIDEN UNIVERSITY,NL
PhD, Em Professor of Pharmacology
Prof. Bart CJM Fauser
UNIVERSITY OF UTRECHT,NL
MD, PhD, FRCOG, Em Professor of Reproductive Medicine
Dr. Nel Duijvestijn
MCH HOSPITAL THE HAGUE, NL
Endocrinologist and expert in diabetes and glucose sensoring
Prof. Jeffrey T. Jensen
OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, USA
MD, MPH, Depts Obs & Gynecol and Public Health and Preventive Medicine
Tjeerd Kalff
EX-CEO ORGANON PHARMACEUTICALS
Responsible for first innovative vaginal ring world wide (Nuvaring®). “That was a first generation ring, this one opens exponentially more possibilities.”
Cees van Lede
EX-CEO AKZO
✞ 2020
“ The LiGalli MedRing 2.0 makes me smile. It is a contemporary innovation of Organon’s first worldwide vaginal ring in the past”
Prof. Karl Malcolm
QUEEN’S UNIVERSITY OF BELFAST, N. IRE
Professor of Drug Delivery at School of Pharmacy expert in vaginal rings and animal studies
Prof. H. van der Vaart
UNIVERSITY MEDICAL CENTER UTRECHT, NL
Urogynecologist and expert in overactive bladder
Interested in collaborating?
We are looking for partners as we move our business to the market. Reach out below if you’d like to work together.
Get in touch
Office
Leiden Bio Science Park – BioPartner 1
Address
J.H. Oortweg 21
2333 CH Leiden
The Netherlands
Willem de Laat MD, PhD, MBA
CEO & FOUNDER Willem is the visionary father of LiGalli and acts as CEO and CTO of the company. His responsibilities are product development, partnerships, and external communication.